Evidence map›Paper›PMID 38172199›Full record

ArticleProstate cancer and prostatic diseases2025

Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board.

Stacy Loeb, Heather H Cheng, Channing J Paller, Emily Weg, Jennifer Johnson, Laura Gross, Scott W Keith, Jessica Russo, Feighanne Hathaway, Adrian Rivera and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stacy LoebDepartment of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA. stacyloeb@gmail.com.ORCID http://orcid.org/0000-0003-3933-9207
Heather H ChengDivision of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-1365-0702
Channing J PallerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MA, USA.ORCID http://orcid.org/0000-0003-3658-1858
Emily WegDepartment of Radiation Oncology, University of Washington, Seattle, WA, USA.
Jennifer JohnsonDepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Laura GrossYale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
Scott W KeithDivision of Biostatistics and Bioinformatics, Sidney Kimmel Medical Colllege, Thomas Jefferson University, Philadelphia, PA, USA.
Jessica RussoMD Anderson Cancer Center at Cooper University Health Care, Camden, NJ, USA.
Feighanne HathawayHematology/Oncology, Biological Sciences Division, University of Chicago, Chicago, IL, USA.
Adrian RiveraDepartment of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA.
Veda N GiriYale School of Medicine and Yale Cancer Center, New Haven, CT, USA.

Funding

U.S. Department of Defense (United States Department of Defense) 080-27000-X17501
6 · The paper itself

Abstract

backgroundGermline testing is important in prostate cancer and evaluation can be complex.

methodsWe instituted a monthly multi-disciplinary virtual genetics tumor board (7/2021-3/2022). Participants and panelists were surveyed on usefulness and acceptability.

results101 participants attended a session, and 77 follow-up surveys were completed. Over 90% participants and 100% panelists endorsed usefulness of the case discussions and usability of the technology. The majority felt it provided new information they will use.

conclusionsA multidisciplinary genetics board was successfully developed to address complexity in prostate cancer genetics. The virtual platform may enhance dissemination of expertise where there are regional gaps.

Indexed as

Genetic TestingGerm-Line MutationHealth Knowledge, Attitudes, PracticeHealth PersonnelProstatic NeoplasmsAdultAgedGenetic Predisposition to DiseaseHumansMaleMiddle AgedSurveys and Questionnaires

Identifiers

PMID38172199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.